Saturday , November 18 2017
Home / Conditions / Type 2 Diabetes / The Present and Future of Insulin Therapy, Part 9

The Present and Future of Insulin Therapy, Part 9

In this week’s Homerun Slides, we look at SGLT2 Inhibition as a novel treatment strategy for Type 2 Diabetes.

To download the complete set in PowerPoint format, just use this link: The Present and Future of Insulin Therapy in the Era of Pathophysiologic Treatment of T2DM, Part 9

Catch up on past Homerun Slides for The Present and Future of Insulin Therapy series.

To download part 8, click here:  The Present and Future of Insulin Therapy in the Era of Pathophysiologic Treatment of T2DM, Part 8

To download part 7, click here: The Present and Future of Insulin Therapy in the Era of Pathophysiologic Treatment of T2DM, Part 7

To download part 6, click here: The Present and Future of Insulin Therapy in the Era of Pathophysiologic Treatment of T2DM, Part 6

To download part 5, click here: The Present and Future of Insulin Therapy in the Era of Pathophysiologic Treatment of T2DM, Part 5

To download part 4 and for links to parts 1 through 3, click here: The Present and Future of Insulin Therapy in the Era of Pathophysiologic Treatment of T2DM, Part 4

To download part 3, click here: The Present and Future of Insulin Therapy in the Era of Pathophysiologic Treatment of T2DM, Part 3

To download part 2, click here: The Present and Future of Insulin Therapy in the Era of Pathophysiologic Treatment of T2DM, Part 2

To download part 1, click here: The Present and Future of Insulin Therapy in the Era of Pathophysiologic Treatment of T2DM, Part 1

See more SGLT-2 Resources